Extracellular Matrix Remodeling Factors as Markers of Carotid Artery Atherosclerosis

Figure 4

Comparison of (a) osteoprotegerin (OPG), (b) fibronectin (FN), (c) matrix metalloproteinase 2 proenzyme (proMMP-2), (d) matrix metalloproteinase 9 proenzyme (proMMP-9), (e) matrix metalloproteinase 2 active form (MMP-2), and (f) matrix metalloproteinase 9 active form (MMP-9) in atherosclerotic plaque and reference tissue, from the same patients. The middle lines represent the median, and the whiskers extend from the 25th to the 75th percentiles.

(a)

(b)

(c)

(d)

(e)

(f)